Results 111 to 120 of about 14,081 (169)

Clinician and patient attitudes toward locoregional treatment of oligometastatic oesophago-gastric cancers: a mixed-methods study. [PDF]

ESMO Gastrointest Oncol
Lakha AS, Gordon-Weeks A, Markar SR.
europepmc   +1 more source

Radiotherapy for Metastatic Bladder Cancer in the Era of Modern Systemic Therapies. [PDF]

Cureus
Herver Vazquez ME, Mora Montoya MJ, Coria Dominguez LA, Granados Sanchez EF.   +3 more
europepmc   +1 more source

Treatment of oligometastatic lung cancers: new data, new drivers, new approaches. [PDF]

BMJ Oncol
O'Dwyer N, Palma DA.
europepmc   +1 more source

Solitary Testicular Metastasis as the Only Site of Recurrence in Prostate Adenocarcinoma. [PDF]

Cureus
Harchaoui MA, Masaoudi B, Azzakhmam M, Alami M, Ameur A.   +4 more
europepmc   +1 more source

Recurrent prostate adenocarcinoma after radical prostatectomy: Principles of multidisciplinary management across a spectrum of disease. [PDF]

CA Cancer J Clin
Kishan AU, Zekster Y, Singer AE, Taparra K, Valle LF, Steinberg ML, Nickols NG, Reiter RE, Czernin J, Calais J, Lee JK, Hardesty LR, Rettig MB.   +12 more
europepmc   +1 more source

Efficacy and Safety of Sintilimab in Combination With Anlotinib and Chemoradiotherapy as First-Line Treatment for Driver Gene-Negative Oligometastatic Non-small Cell Lung Cancer: A Real-World Cohort Study. [PDF]

Dose Response
Jiang J, Ni C, Wu C, Song Y, Zhu H.
europepmc   +1 more source

External validation of a genomic signature for oligometastatic non-small cell lung cancer

Objective: We previously presented a genomic signature predictive of both oligometastatic disease state and oligoprogression in patients with brain metastases.
Xing, Fei, D'Agostino, Ralph B., Jr., Cramer, Christina K., Li, Wencheng, Abdulhaleem, Mohammed, Wang, Yuezhu, Lanier, Claire M., Glynn, Sarah, Petty, W. Jeffrey, Whitlow, Christopher T., Young, Patrick, Smith, Margaret R., Lycan, Thomas W., Ruiz, Jimmy, Choi, Ariel R., Su, Jing, Chan, Michael D., Farris, Michael K.   +17 more
core  

Efficacy and safety of metastasis-directed therapy for oligometastatic cancer: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Radiat Oncol
Chen D, Khoshkish E, Jomy J, Arnold K, Yi J, Palma D, Liu M, Ye XY, Liu Z, Boldt G, Wong P, Raman S.   +11 more
europepmc   +1 more source

Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT Cohort. [PDF]

J Nucl Med
Bauckneht M, Belgioia L, Albano D, Triggiani L, Linguanti F, Urso L, Mazzola R, Rizzo A, D'Angelo E, Dondi F, Mataj E, Pedersoli G, Abenavoli EM, Vaggelli L, Detti B, Ortolan N, Malorgio A, Guarneri A, Garrou F, Passoni J, Fiorini M, Grimaldi S, Ghedini P, Iorio GC, Iudicello A, Rovera G, Fornarini G, Zanardi E, Bongiovanni D, Marcenaro M, Agosti A, Timon G, Salgarello M, Racca M, Bartolomei M, Panareo S, Ricardi U, Bertagna F, Alongi F, Barra S, Morbelli S, Lanfranchi F, Sambuceti G.   +42 more
europepmc   +1 more source

Curative Oligometastatic Radiation Therapy: Why We Should Redefine Intent When Cure May Be Attainable. [PDF]

Adv Radiat Oncol
Wallach JB, Kelly MD, Shapiro R, McGunigal M, Lee SP, Hoffman-Hogg L, Wechsler G, Gutt R, Veterans Health Administration Palliative Radiotherapy Task Force.   +8 more
europepmc   +1 more source